Horm Metab Res 2007; 39(10): 710-716
DOI: 10.1055/s-2007-985897
Review

© Georg Thieme Verlag KG Stuttgart · New York

Resistin- and Obesity-associated Metabolic Diseases

M. A. Lazar 1
  • 1Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and The Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, USA
Further Information

Publication History

received 16.10.2006

accepted 01.02.2007

Publication Date:
22 October 2007 (online)

Zoom Image

Abstract

The link between obesity and diabetes is strong as well as complex. Fat cells produce many circulating regulators of insulin sensitivity, including pro-inflammatory cytokines. In rodents, resistin is produced by adipose tissue, and is a significant regulator of glucose metabolism and insulin sensitivity. In humans, resistin is derived made mainly from macrophages. Given the emerging interrelationship between inflammation and metabolic disease, hyperresistinemia may be a biomarker, and/or a mediator, of metabolic and inflammatory diseases in humans as well as in rodents.